Clinical Trial Update: Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17 [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding trial evaluated WS6788A and LSN03-016011/A against CS17-expressing enterotoxigenic E. coli strains in a challenge-model setup to explore …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• LSN03-016011/A
• WS6788A

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Travelers' Diarrhea | Phase 1 | Status: COMPLETED